These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3532077)

  • 21. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients.
    Perez-Garcia R; Anaya F; Chisvert J; Valderrabano F
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164-6. PubMed ID: 8643200
    [No Abstract]   [Full Text] [Related]  

  • 22. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Allstate scientific conference on metabolism in uremia and on the therapy of renal insufficiency using hemodialysis].
    Horák J
    Vnitr Lek; 1970 Jul; 16(7):718-20. PubMed ID: 5456660
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
    Zucchelli P; Fusaroli M; Sasdelli M; Stallone C
    Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipid metabolism in hemofiltration. Comparison with the lipid pattern of hemodialyzed patients].
    Civati G; Galato R; Franceschini G; Guastoni C; Perego A; Minetti L
    Minerva Nefrol; 1980; 27(4):669-74. PubMed ID: 7254694
    [No Abstract]   [Full Text] [Related]  

  • 27. Zinc metabolism in renal failure.
    Condon CJ; Freeman RM
    Ann Intern Med; 1970 Oct; 73(4):531-6. PubMed ID: 5506004
    [No Abstract]   [Full Text] [Related]  

  • 28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study.
    Brodersen HP; Holtkamp W; Larbig D; Beckers B; Thiery J; Lautenschläger J; Probst HJ; Ropertz S; Yavari A
    Nephrol Dial Transplant; 1995; 10(9):1780. PubMed ID: 8559509
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin metabolism in chronic uremia and in the anephric state: effect of the dialytic treatment.
    Navalesi R; Pilo A; Lenzi S; Donato L
    J Clin Endocrinol Metab; 1975 Jan; 40(1):70-85. PubMed ID: 1089679
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of phosphate retention and hyperphosphatemia in uremia.
    Hercz G; Coburn JW
    Kidney Int Suppl; 1987 Oct; 22():S215-20. PubMed ID: 3323615
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of chronic uremia with intermittent peritoneal dialysis].
    Kopp H
    Munch Med Wochenschr; 1967 Apr; 109(16):879-86. PubMed ID: 5631547
    [No Abstract]   [Full Text] [Related]  

  • 33. Zinc, copper, magnesium and calcium in dialyzed and nondialyzed uremic patients.
    Mansouri K; Halsted JA; Gombos EA
    Arch Intern Med; 1970 Jan; 125(1):88-93. PubMed ID: 5410656
    [No Abstract]   [Full Text] [Related]  

  • 34. [The importance of amino acid substitution for the protein metabolism in patients treated by periodical hemodialysis].
    Kult J; von Finck M; Frank P; Heidland A
    Infusionstherapie (1973); 1973 Dec; 1(2):124-7. PubMed ID: 4219012
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic renal disease. Some sociological aspects of dialysis and transplantation.
    Rubini ME; Goldman R
    Calif Med; 1968 Feb; 108(2):90-5. PubMed ID: 4867565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of chronic uremia by dialysis].
    Lampainen E
    Duodecim; 1983; 99(17):1218-26. PubMed ID: 6357721
    [No Abstract]   [Full Text] [Related]  

  • 39. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis: determination of phosphoremia during some dynamic tests].
    Redaelli B; Salvadeo A; Imbasciati E; Ponticelli C
    Arch Ital Urol Nefrol; 1967; 39(6):459-67. PubMed ID: 5606789
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism and toxicity of aliphatic amines.
    Simenhoff ML
    Kidney Int Suppl; 1975 Feb; (3):314-7. PubMed ID: 1057706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.